Q-Pharm

Australian early phase clinical trials company at the Herston health precinct in Brisbane, Queensland, established in 2002 and wholly owned by the QIMR Berghofer Medical Research Institute from 2014 until Nucleus Network acquired it in January 2019. Runs a sixty two bed dedicated phase one and two facility that has conducted more than four hundred clinical trials accepted by regulators in Australia, Europe, North America and Asia, including first in human, healthy volunteer and malaria challenge studies.